Evidence map›Paper›PMID 36555660›Full record

ArticleInternational journal of molecular sciences2022

Differential Regulation of Two Arms of mTORC1 Pathway Fine-Tunes Global Protein Synthesis in Resting B Lymphocytes.

Gagan Dev, Amanpreet Singh Chawla, Suman Gupta, Vineeta Bal, Anna George, Satyajit Rath, G Aneeshkumar Arimbasseri

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Gagan DevNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, Delhi, India.
Amanpreet Singh ChawlaNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, Delhi, India.ORCID 0000-0001-5265-3431
Suman GuptaNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, Delhi, India.
Vineeta BalIndian Institute of Science Education and Research, Dr. Homi Bhabha Rd., Pashan, Pune 411008, Maharashtra, India.
Anna GeorgeTranslational Health Sciences and Technology Institute, NCR Biotech Science Cluster, Faridabad 121001, Haryana, India.
Satyajit RathIndian Institute of Science Education and Research, Dr. Homi Bhabha Rd., Pashan, Pune 411008, Maharashtra, India.
G Aneeshkumar ArimbasseriNational Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110067, Delhi, India.
Indian Institute of Science Education and Research Pune · INNational Institute of Immunology · INCedars-Sinai Medical Center · USTranslational Health Science and Technology Institute · INUniversity of Dundee · GB

Funding

Department of Biotechnology BT/PR27638/GET/119/266/2018Department of Biotechnology BT/PR29599/PFN/20/1393/2018Science and Engineering Research Board ECR/2017/000115Science and Engineering Research Board SB/S21RJN-063/2016
6 · The paper itself

Abstract

Protein synthesis is tightly regulated by both gene-specific and global mechanisms to match the metabolic and proliferative demands of the cell. While the regulation of global protein synthesis in response to mitogen or stress signals is relatively well understood in multiple experimental systems, how different cell types fine-tune their basal protein synthesis rate is not known. In a previous study, we showed that resting B and T lymphocytes exhibit dramatic differences in their metabolic profile, with implications for their post-activation function. Here, we show that resting B cells, despite being quiescent, exhibit increased protein synthesis in vivo as well as ex vivo. The increased protein synthesis in B cells is driven by mTORC1, which exhibits an intermediate level of activation in these cells when compared with resting T cells and activated B cells. A comparative analysis of the transcriptome and translatome of these cells indicates that the genes encoding the MHC Class II molecules and their chaperone CD74 are highly translated in B cells. These data suggest that the translatome of B cells shows enrichment for genes associated with antigen processing and presentation. Even though the B cells exhibit higher mTORC1 levels, they prevent the translational activation of TOP mRNAs, which are mostly constituted by ribosomal proteins and other translation factors, by upregulating 4EBP1 levels. This mechanism may keep the protein synthesis machinery under check while enabling higher levels of translation in B cells.

Indexed as

Protein BiosynthesisRibosomal ProteinsB-LymphocytesMechanistic Target of Rapamycin Complex 1T-LymphocytesMechanistic Target of Rapamycin Complex 1Ribosomal Proteins4EBP1B cellmTORC1protein synthesisRibo-SeqT cell

Identifiers

PMID36555660
PMCPMC9784905
OpenAlexW4312211918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.